These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 22817618)
1. Improving oversight of innovative medical interventions in Texas, USA. Levine AD Regen Med; 2012 Jul; 7(4):451-3. PubMed ID: 22817618 [No Abstract] [Full Text] [Related]
2. Stem cells. Texas Medical Board approves rules for controversial treatment. Kaiser J Science; 2012 Apr; 336(6079):284. PubMed ID: 22517830 [No Abstract] [Full Text] [Related]
3. Texas prepares to fight for stem cells. Cyranoski D Nature; 2011 Sep; 477(7365):377-8. PubMed ID: 22049545 [No Abstract] [Full Text] [Related]
4. Texas stem cell rules may impede clinical research. Arnold C Lancet; 2012 May; 379(9828):1776. PubMed ID: 22586718 [No Abstract] [Full Text] [Related]
8. The Food and Drug Administration, regenerative sciences, and the regulation of autologous stem cell therapies. von Tigerstrom B Food Drug Law J; 2011; 66(4):479-506, i. PubMed ID: 24505826 [TBL] [Abstract][Full Text] [Related]
9. FDA oversight of cell therapy clinical trials. Au P; Hursh DA; Lim A; Moos MC; Oh SS; Schneider BS; Witten CM Sci Transl Med; 2012 Aug; 4(149):149fs31. PubMed ID: 22932219 [TBL] [Abstract][Full Text] [Related]
11. FDA should stand firm on stem-cell treatments. Nature; 2016 Jul; 535(7610):7-8. PubMed ID: 27383946 [No Abstract] [Full Text] [Related]
12. Stem cells. U.S. regulation of stem cells as medical products. Sipp D; Turner L Science; 2012 Dec; 338(6112):1296-7. PubMed ID: 23224541 [No Abstract] [Full Text] [Related]
13. US stem cell clinics, patient safety, and the FDA. Turner L Trends Mol Med; 2015 May; 21(5):271-3. PubMed ID: 25945404 [TBL] [Abstract][Full Text] [Related]
14. FDA regulation of stem cell-based products. Fink DW Science; 2009 Jun; 324(5935):1662-3. PubMed ID: 19556496 [TBL] [Abstract][Full Text] [Related]
15. Texas H.B. 810: Increased Access to Stem Cell Interventions or an Increase in Unproven Treatments? Matthews K; Kunisetty B; Sprung K Stem Cells Dev; 2018 Nov; 27(21):1463-1465. PubMed ID: 30122128 [TBL] [Abstract][Full Text] [Related]
16. Allowing innovative stem cell-based therapies outside of clinical trials: ethical and policy challenges. Hyun I J Law Med Ethics; 2010; 38(2):277-85. PubMed ID: 20579251 [TBL] [Abstract][Full Text] [Related]
17. FDA challenges stem-cell clinic. Cyranoski D Nature; 2010 Aug; 466(7309):909. PubMed ID: 20725009 [No Abstract] [Full Text] [Related]
18. Are stem cells drugs? The regulation of stem cell research and development. Rosen MR Circulation; 2006 Oct; 114(18):1992-2000. PubMed ID: 17075025 [TBL] [Abstract][Full Text] [Related]
19. Texas signals support for unproven stem cell therapies. Servick K Science; 2017 Jun; 356(6344):1219. PubMed ID: 28642387 [No Abstract] [Full Text] [Related]
20. A RAT by Another Name: 21 Riley MF Am J Law Med; 2018 May; 44(2-3):291-308. PubMed ID: 30106653 [No Abstract] [Full Text] [Related] [Next] [New Search]